Jesse Riordan
University of Iowa
H-index: 18
North America-United States
Top articles of Jesse Riordan
ABCB1 promotes uveal melanoma cell resistance to FR900359 and identifies a tumor cell subpopulation with a distinct gene expression signature
Cancer Research
2024/3/22
Abstract A026: Identifying mechanisms to target in combination with trametinib to improve therapeutic efficacy in low-grade serous ovarian cancer
Cancer Research
2024/3/4
Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance
NAR cancer
2024/3/1
Understanding cancer drug resistance with Sleeping Beauty functional genomic screens: Application to MAPK inhibition in cutaneous melanoma
Iscience
2023/10/20
Identifying mechanisms of therapeutic resistance in low-grade serous ovarian cancer (2282)
Gynecologic oncology
2023/9/1
Jesse Riordan
H-Index: 14
Adam Dupuy
H-Index: 26
Characterization of genetic mechanisms of ovarian tumor progression using sleeping beauty mutagenesis in vivo (2296)
Gynecologic oncology
2023/9/1
Jesse Riordan
H-Index: 14
Adam Dupuy
H-Index: 26
SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas
NPJ precision oncology
2022/10/21
WDR26 and MTF2 are therapeutic targets in multiple myeloma
Journal of Hematology & Oncology
2021/12
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer
The Journal of clinical investigation
2021/1/4
Abstract B08: Identification and characterization of Rho family GTPases as drivers of drug resistance in BRAFV600 mutant melanoma
Cancer Research
2020/10/1
Abstract PR17: Sleeping Beauty mutagenesis reveals a Src-dependent DBL GEF family signaling mechanism driving MAPK inhibitor resistance in BRAF mutant melanoma
Cancer Research
2020/10/1
691 RNA BINDING PROTEIN APOBEC1 COMPLEMENTATION FACTOR (A1CF) ALTERS HEPATIC LIPOGENIC AND PROLIFERATIVE PATHWAYS PROMOTING SPONTANEOUS TUMORIGENESIS.
Gastroenterology
2020/5/1
